Position in BBIO
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$31,477,922
-$16,142,839 QoQ
Shares Held
423,888
-31.9% QoQ
Ownership
0.216%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BBIO Over Time
Shares Held
Position Value (USD)
Derivatives in BBIO
reported options exposure · as of Mar 31, 2026CallValue
$0
CallShares
0
PutValue
$1,514,904
PutShares
20,400
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026BARCLAYS PLC holds $1,494,072,071 across 362 Biotechnology names. BBIO ranks #13 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
663,263 | $296,173,457 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
313,093 | $241,908,173 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
220,623 | $72,997,531 | |
| 4 | MRNA |
Moderna, Inc.
|
932,269 | $47,359,264 | |
| 5 | INSM |
INSMED Inc
|
275,731 | $45,087,531 | |
| 6 | ROIV |
Roivant Sciences Ltd.
|
1,415,848 | $39,218,988 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
383,179 | $37,264,156 | |
| 8 | TERN |
Terns Pharmaceuticals, Inc.
|
669,601 | $35,301,364 |
All Filings in BBIO
Export CSV
32 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $31,477,922 | 423,888 | Shares | Defined | 2026-05-15 | |
| 2026-03-31 | $1,514,904 | 20,400 | Put | Defined | 2026-05-15 | |
| 2025-12-31 | $1,560,396 | 20,400 | Put | Sole | 2026-02-13 | |
| 2025-12-31 | $47,620,761 | 622,575 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,059,576 | 20,400 | Put | Sole | 2026-03-31 | |
| 2025-09-30 | $37,368,127 | 719,448 | Shares | Sole | 2026-03-31 | |
| 2025-06-30 | $40,309,047 | 933,512 | Shares | Sole | 2026-02-27 | |
| 2025-03-31 | $13,442,128 | 388,838 | Shares | Sole | 2026-03-17 | |
| 2024-12-31 | $12,279,674 | 447,510 | Shares | Sole | 2026-03-19 | |
| 2024-09-30 | $13,875,903 | 545,008 | Shares | Sole | 2026-03-31 | |
| 2024-06-30 | $10,468,002 | 413,265 | Shares | Sole | 2026-03-23 | |
| 2024-03-31 | $1,128,580 | 36,500 | Put | Sole | 2026-03-24 | |
| 2024-03-31 | $12,527,794 | 405,168 | Shares | Sole | 2026-03-24 | |
| 2024-03-31 | $927,600 | 30,000 | Call | Sole | 2026-03-24 | |
| 2023-12-31 | $262,405 | 6,500 | Put | Sole | 2026-03-24 | |
| 2023-12-31 | $29,956,073 | 742,038 | Shares | Sole | 2026-03-24 | |
| 2023-09-30 | $12,695,572 | 481,440 | Shares | Sole | 2026-03-26 | |
| 2023-06-30 | $10,133,620 | 589,164 | Shares | Sole | 2026-03-27 | |
| 2023-03-31 | $34,818 | 2,100 | Call | Sole | 2026-03-30 | |
| 2023-03-31 | $11,123,173 | 670,879 | Shares | Sole | 2026-03-30 | |
| 2022-12-31 | $9,158,363 | 1,201,885 | Shares | Sole | 2026-03-30 | |
| 2022-09-30 | $3,244,584 | 326,417 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $267,297 | 29,438 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $432,247 | 42,586 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $3,237,154 | 194,074 | Shares | Sole | 2022-02-23 | |
| 2021-09-30 | $4,197,957 | 89,566 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $3,841,698 | 63,020 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $6,173,490 | 100,219 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $2,591,817 | 36,448 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $1,252,117 | 33,372 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $1,483,363 | 45,488 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $851,556 | 29,364 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||